Pharma Dro P 10ml/100mg Drostanolone Propionate – Pharmacom
Potent anabolic activity (62%) with low androgenic index (25%). Fast‑acting ester, half‑life 1–1.5 days for short cutting cycles. No water retention or aromatization; mild diuretic improves muscle density. 300–700 mg/week typical dosage.
- No water retention
- Fast ester, ideal for short cycles
- Mild diuretic enhances definition
- Safe for weight‑class athletes
Pharma Dro P 10ml/100mg Drostanolone Propionate – Pharmacom
Key Features of Pharma Dro P
- Potency & Purity: 100 mg per 10 ml vial, formulated with pharmaceutical-grade Drostanolone Propionate.
- Fast‑acting: Half‑life of 1–1.5 days – ideal for short cutting cycles.
- No water retention: Promotes lean muscle definition without bloating.
- Anti‑estrogenic: Does not aromatize; can help reduce estrogen‑related side effects.
Pharmacology & Composition
| Attribute | Value |
|---|---|
| Chemical Name | (2α,5α,17β)-2-Methyl-3‑oxoandrostan‑17‑yl propanoate |
| Molecular Formula | C23H36O3 |
| Anabolic Activity Index | 62 % |
| Androgenic Activity Index | 25 % |
| Active Half‑Life | 1–1.5 days |
| Dosage Range (Men) | 300–700 mg/week |
| Aromatization | No |
| Water Retention | No |
| Liver Toxicity | Low |
| Tendon Brittleness | Minimal |
Administration Guidelines
- Injection Site: Intramuscular, preferably in the gluteal or deltoid muscle.
- Dosing Frequency: 2–3 times per week to maintain steady blood levels.
- Typical Cycle Length: 4–8 weeks for cutting protocols; longer cycles may be used with caution.
- Mixing Instructions: Shake vial gently before use; do not exceed recommended volume per injection.
Expected Effects
- Enhanced muscle hardness and definition.
- Reduction of body fat by 5–7 % during a well‑managed cycle.
- Improved lean muscle mass without significant water retention.
- Stabilized estrogen levels due to anti‑estrogenic properties.
Side Effect Profile
- Common: Acne, mild mood swings, hair loss in predisposed individuals.
- Cardiovascular: Modest impact on cholesterol; monitor lipid panels if using high doses.
- Joint & Tendon: Lower risk of brittleness compared to stanozolol.
- Liver: Low hepatotoxicity but still recommend periodic liver function tests.
- Estrogenic Symptoms: Rare due to lack of aromatization; gynecomastia unlikely.
Why Choose Pharma Dro P for Cutting Cycles?
- Fast onset and short half‑life allow precise control over muscle definition stages.
- Anti‑estrogenic action eliminates the need for estrogen blockers during a cutting phase.
- Minimal water retention keeps you looking sharp at weigh‑ins.
- Lower cardiovascular impact makes it safer for extended use than some alternatives.
This product is available exclusively through PoseidonRX, ensuring reliable sourcing and secure shipping.


There are no reviews yet.